CYTOTOXIC drugs are being used increasingly in the treatment of advanced malignant disease, and a great variety of these agents is now available. However, individual tumours, even those which appear to be identical by histological and other criteria, may differ considerably in their response to the drugs. Therefore a reliable method of assessing the effect of cytotoxic drugs on human tumour cells in the laboratory, which would allow the most suitable agent to be selected for clinical use would be of value.
CYTOTOXIC drugs are being used increasingly in the treatment of advanced malignant disease, and a great variety of these agents is now available. However, individual tumours, even those which appear to be identical by histological and other criteria, may differ considerably in their response to the drugs. Therefore a reliable method of assessing the effect of cytotoxic drugs on human tumour cells in the laboratory, which would allow the most suitable agent to be selected for clinical use would be of value.
The effects of cytotoxic drugs on human tumour cells have often been examined in vitro, but these investigations have failed to produce consistently reliable results. It was therefore felt that an examination of the response of tumour cells to cytotoxic drugs under less abnormal conditions in vivo would be of interest, and might yield results with a more valid clinical application.
In order to achieve this, grafts of human tumours must be induced to obtain a blood supply and to grow following transplantation to a laboratory animal host. The cheek pouch of the golden hamster is known to possess immunological privilege in the sense that grafts of homologous and heterologous tissue will often survive for long periods at this site. Billingham, Ferrigan and Silvers (1960) and Cohen (1961) have demonstrated that, although skin homografts and heterografts to the trunk of the hamster are normally rejected within 12 days, grafts to the lateral wall of the cheek pouch will often survive for many months. And it has also been shown that a significant proportion of human tumours will survive and grow for short periods at the cheek pouch, especially if the host is conditioned with small doses of cortisone. Handler, Davis and Sommers (1956) reported that 38% of 68 human tumours showed histological evidence of survival and growth 5-58 days after transplantation, and Patterson, Patterson and Chute (1957) observed growth in 52% of 90 human tumours. A small proportion (10%) grew well, and it was possible to transfer these to further hamster hosts.
All the available evidence suggests that human tumours maintain their functional and histological identity after transplantation to the hamster cheek pouch. Toolan (1955) has stressed that very little alteration in histological structure takes place. Levan (1956) has demonstrated that human tumours retain their chromosomal identity. Korngold and Lipari (1955) and Yohn et al. (1962) have reported that serially propagated human tumours retain their tumour antigens. Pierce, Dixon and Verney (1958) and Hertz (1959) have shown that hormonal function can be maintained by human testicular tumours and choriocarcinomas growing at the hamster cheek pouch.
Handler (1958) investigated the response of serially propagated tumours of human origin to a variety of cytotoxic agents, and demonstrated that the response of a tumour growing on the cheek pouch can be related to the dose of drug administered intraperitoneally. Reproducible dose-response curves were obtained. Burt et al. (1966) and Sommers, Friedell and Robinson (1966) , using different tumours and cytotoxic agents, have confirmed these findings. Sanders (1963) has introduced an observation chamber which enables the lateral wall of the hamster cheek pouch and any tissue transplanted to it to be examined microscopically in vivo. The chamber consists of 2 simple perspex components which fit together to enclose part of the wall of the cheek pouch and any tissue grafted to it ( Fig. 1 and 2 ). Introduction of a light source to the lumen of the pouch provides transillumination for direct microscopy in the anaesthetised animal. The useful life of the preparation is 2-3 weeks and during this time any changes which take place in the cheek pouch membrane, or in the tissue transplanted to it, can be readily observed and photographed. Goodall, Sanders and Shubik (1965) and Warren and Shubik (1966) have studied the vascularisation and growth of hamster tumours transplanted to the chamber. Delorme et al. (1965) have used the chamber to examine the growth of human tumour cell suspensions, and Ellis and Sewell (1966) have reported vascularisation and growth of fragments of human lung, bladder and stomach tumours within the chamber. It was therefore thought that the technique would be suitable for an examination in vivo of the response of human tumours to cytotoxic drugs.
METHODS

Transplantation
Golden hamsters of either sex, 25-40 weeks old and weighing 100-200 g. were used. In each case the observation chamber was inserted in the right cheek pouch only. A modified pattern, described by Sewell (1966 ), of Sanders' (1963 original observation chamber was used. The techniques ofinsertion ofthe chamber and of microscopical examination have been described in detail by Goodall, Sanders and Shubik (1965) and Sewell (1966) .
Tumour specimens were obtained as soon as possible after removal from the patient. If a large tumour mass was removed a small portion of it, usually about 0 5-1'0 cu.cm. in size, was then selected and excised with sterile instruments. In some instances only a small biopsy specimen was obtained. and liver. Tissue from each tumour was transplanted to 2-10 hamsters at a time. In the majority of cases 4 hamsters were used. The tumours were examined microscopically in vivo every 1-2 days for 10-21 days. At the end of this period the animals were killed. The implants were then excised and fixed in formalin for histological examination. Increase in size of individual tumour grafts was assessed by measurement in vivo, and confirmed by subsequent histological examination. It was not possible to estimate the volume of the implants because sufficiently accurate measurements of tumour depth could not be obtained. Therefore, as the depth of each implant remained almost constant within the rigid confines of the chamber, and was always less than 0 5 mm., an estimate of tumour surface area (T.S.A.) was used as the index of tumour size (Fig. 3 ). This was defined as the area of tumour visible on in vivo microscopy, and was measured with a micrometer eyepiece. If the T.S.A. increased by 100% or more, growth was said to have occurred. This was always confirmed by subsequent histological examination of the implant. Smith.
CYTOTOXIC AGENTS AND HUMAN TUMOURS
Cytotoxic agents Nitrogen mustard and methotrexate were the drugs used. Sixteen human tumours were used for cytotoxic studies (Table II) . The response of implants from 10 tumours to both drugs was examined, and the response of implants from 6 tumours to either drug alone. One or more untreated control implants were used for comparison in every case.
Cytotoxic treatment was started as soon as the tumour implants were observed to have been completely vascularised. The cytotoxic agents were administered intraperitoneally by single, daily injections for 7 successive days. The dosages were calculated, using the criteria of Freireich et al. (1966) , to be approximately equivalent to total human dose levels of 0 4 mg./kg. of nitrogen mustard and 2*0 mg./kg. of methotrexate. In each case the total dose administered to the Implants which grew during the period of cytotoxic therapy and remained viable were classified as " drug-resistant ". Viability was assessed on histological examination of the grafts. Those which failed to grow and were subsequently lound to be non-viable were classified as " drug-sensitive ". Intermediate results were classified as" equivocal ". These findings were only accepted if untreated control implants showed measurable growth, and remained histologically viable during the period of the study.
RESULTS
Vas8cularisation and growth
It was observed that either the tumour implants received a blood supply by ingrowth of host blood vessels within a week of grafting, or they remained Of the 32 tumours examined 20 were vascularised and 12 remained avascular. The time taken for implants from different tumours to obtain a blood supply varied from 3-7 days, but the response to implants of the same tumour in different hamsters was consistently similar. Grafts of the tumours which were vascularised all received a blood supply within 1-2 days of each other; grafts of tumours which did not receive a blood supply all remained avascular. Implants from 14 tumours were observed to grow within the chamber. These implants always received a blood supply before they began to increase in size. Six tumours which obtained a blood supply failed to grow. Implants of 12 tumours which were not vascularised also did not grow. Histological examination revealed that implants which had been vacularised usually, but not invariably, contained viable tumour cells, whereas implants which had failed to receive a blood supply within a week of transplantation were always non-viable.
These observations showed that implants from individual human tumours are able to induce a consistently similar microvascular response in different hamsters. This in turn suggested that the behaviour of human tumours within the Sanders' observation chamber is probably sufficiently reproducible for valid results to be obtained from studies with cytotoxic drugs.
Response to cytotoxic drugs Grafts from 14 of the 16 tumours studied increased in size after transplantation to the cheek pouches of untreated control animals (Table II) . In most of these cases growth was relatively slight, and in no instance was the chamber cavity completely filled by tumour tissue. Histological examination after the observation period of 10-14 days showed that these implants contained viable tumour cells (Fig. 4) and that mitotic figures were present. Comparison with sections of the parent neoplasm demonstrated that tissue differentiation was usually retained by the tumour implants.
Two tumours failed to grow in control animals. Examinations of implants from one, a mesenchymal sarcoma, revealed viable tumour cells, but implants of the other, a colonic carcinoma, contained only a few cells of possible tumour origin.
The effect of nitrogen mustard was studied on implants of 13 tumours (Table  III) . Five showed measurable growth during the period of cytotoxic therapy. On histological examination 2 of these were assessed as viable and 3 as non-viable. (Fig. 5) , but the remaining 6 were not viable (Fig. 6 ).
The effect of methotrexate was also studied on implants from 13 tumours (Table IV) . Three showed measurable growth during the period of cytotoxic therapy. On histological examination 2 of these were assessed as viable and one On the basis of these observations 6 tumours were assessed as sensitive to the action of nitrogen mustard. These were tumours which did not grow and were found to be non-viable after therapy. In one case, however, this finding was invalidated because 2 control implants also failed to grow. Two tumours which grew during treatment and remained viable were judged to be resistant. The results with the remaining 5 tumours were equivocal.
Nine tumours were assessed as sensitive to the action of methotrexate. In 2 of these cases this finding was invalidated because control implants also failed to grow. Two tumours which grew during treatment and remained viable were judged to be resistant. The results with the remaining 2 tumours were equivocal.
DISCUSSION
The idea of using an in vivo technique to predict the clinical efficacy of cytotoxic agents is attractive in theory. But before a technique sufficiently reliable to be of practical value can be established, the problems of obtaining growth of heterologous tumours, and then of assessing the effects of cytotoxic drugs on these growing tumours have to be overcome.
The present studies confirm that many human tumours will grow for short periods at the hamster cheek pouch. 
SUMMIARY
The Sanders' observation chamber has been used to examine the blood supply, growth and response to cytoxic drugs ofhuman tumours transplanted to the hamster cheek pouch. Grafts from different tumours varied widely in their vascularisation and growth but grafts from the same tumour showed a consistently similar microvascular and growth pattern in different hamsters. Observations on the effect of nitrogen mustard and methotrexate on tumour grafts suggest that human tumours retain their individual sensitivities to cytotoxic agents while growing at the cheek pouch, and that it may therefore be possible to use the technique to predict the clinical response of human tumours to cytotoxic drugs.
